Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arena Pharmaceuticals Inc. (ARNA) (ARNA)

47.115   -0.705 (-1.47%) 04-09 15:33
Open: 48.44 Pre. Close: 47.82
High: 48.85 Low: 46.74
Volume: 209,455 Market Cap: 2367M
Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 48.295 - 48.486 48.486 - 48.651
Low: 46.393 - 46.628 46.628 - 46.831
Close: 47.412 - 47.797 47.797 - 48.129

Technical analysis

as of: 2020-04-09 2:55:25 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 57.06     One year: 66.64
Support: Support1: 39.02    Support2: 32.95
Resistance: Resistance1: 48.85    Resistance2: 57.06
Pivot: 43.49
Moving Average: MA(5): 46.88     MA(20): 42.13
MA(100): 46.16     MA(250): 50.27
MACD: MACD(12,26): 0.64     Signal(9): -0.36
Stochastic oscillator: %K(14,3): 91.78     %D(3): 93.80
RSI: RSI(14): 57.55
52-week: High: 64.48  Low: 32.95  Change(%): -0.2
Average Vol(K): 3-Month: 64483  10-Days: 65940

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ARNA has closed below upper band by 16.5%. Bollinger Bands are 45.2% wider than normal. The large width of the bands suggest high volatility as compared to ARNA's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)
/PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline data from a Phase 1 clinical study evaluating controlled-release…

The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 50.25
Shares Float (M) 50.19
% Held by Insiders 0.15
% Held by Institutions 84.91
Shares Short (K) 3440
Shares Short P. Month (K) 3350

Stock Financials

EPS 7.690
Book Value (p.s.) 21.360
PEG Ratio
Profit Margin 49.30
Operating Margin 61.67
Return on Assets (ttm) 33.4
Return on Equity (ttm) 47.4
Qtrly Rev. Growth -65.3
Gross Profit (p.s.) 11.441
Sales Per Share 16.048
EBITDA (p.s.) 9.961
Qtrly Earnings Growth
Operating Cash Flow (M) 568.69
Levered Free Cash Flow (M) 367.32

Stock Valuations

P/E 6.15
P/E Growth Ratio -0.01
P/BV 2.22
P/CF 4.18

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-06-18
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.